bdawg
Member
"An Australian biotech company is launching a novel attack on Alzheimer's disease. Rather than following the traditional treatment paths, it is taking a new route.
This month the first of 174 patients on an international trial will begin taking a drug to lessen the level of the stress hormone, cortisol, in the brain.
There is evidence to suggest this hormone has role in Alzheimer's. It is not promoted as the sole cause of the disease but rather as a contributing factor.
Current wisdom holds that it is likely that a few factors combine to bring about Alzheimer's. Some think cortisol may be one of them."
"Xanamem™’s novel mechanism of action is to block the activity of a specific enzyme in the brain, the 11β-HSD1 enzyme"
Australian biotech takes a new route to treating Alzheimer's
This month the first of 174 patients on an international trial will begin taking a drug to lessen the level of the stress hormone, cortisol, in the brain.
There is evidence to suggest this hormone has role in Alzheimer's. It is not promoted as the sole cause of the disease but rather as a contributing factor.
Current wisdom holds that it is likely that a few factors combine to bring about Alzheimer's. Some think cortisol may be one of them."
"Xanamem™’s novel mechanism of action is to block the activity of a specific enzyme in the brain, the 11β-HSD1 enzyme"
Australian biotech takes a new route to treating Alzheimer's
